Biotech Company News Biotechnology Coronavirus Coronavirus COVID-19 Infectious Diseases Pharmaceuticals Eureka Therapeutics Announces Successful Preclinical Results of InvisiMask™ Human Antibody Nasal Spray Against SARS-CoV-2 Infection By Staff Reports 1 year ago Newly published study reports InvisiMask™, a self-administered single-dose nasal spray, protects against SARS-CoV-2 infection for
Biotech Company News Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 Infection Control Infectious Diseases rare diseases Vaccines Moderna’s virus vaccine shows overwhelming success in U.S. tests By Staff Reports 1 year ago Moderna said Monday its COVID-19 vaccine is proving highly effective in a major trial, a
Biotech Company News Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 Vaccines CEL-SCI Announced Early Results with COVID 19 LEAPS Vaccine/Treatment By Staff Reports 1 year ago CEL-SCI Corporation announces that it has concluded animal experiments using its LEAPS COVID 19 conjugate
Biotech Company News Biotechnology Coronavirus rare diseases Q BioMed Initiates Rapid Development of Novel COVID-19 Therapeutics By Staff Reports 2 years ago Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, today announced that together with
Biotech Company News Biotechnology Clinical Trials Infectious Diseases rare diseases Aqualung Therapeutics Advances Its Investigational Monoclonal Antibody into Ind-Enabling Studies of Acute Respiratory Distress Syndrome (ARDS) And Ventilator-Induced Lung Injury (VILI) By Staff Reports 2 years ago Aqualung Therapeutics Corporation is developing ALT-100, a therapeutic monoclonal antibody, to combat serious unchecked inflammation.
Biotech Company News Biotechnology Immunotherapies rare diseases Biotech Launches Development of Immunotherapy to Treat COVID-19 Coronavirus Infection By Staff Reports 2 years ago Cancer immunotherapy developer, CEL-SCI Corporation is working on an immunotherapy with the potential to treat the COVID-19
Biotech Company News Biotechnology Infectious Diseases Vaccines Biotech Moderna Ships mRNA Vaccine Against Novel Coronavirus Human Studies By Staff Reports 2 years ago Moderna, Inc.,has released the first batch of mRNA-1273, the Company’s vaccine against the novel coronavirus,
Biotech Company News Biotechnology cancer Merck’s Keytruda wins U.S. FDA approval for bladder cancer drug By Staff Reports 2 years ago The U.S. Food and Drug Administration said on Wednesday it approved Merck & Co Inc’s
Biotech Company News Biotechnology cancer Cell Therapy Clinical Trials drug development Researchers Identify New Therapeutic Target for Colorectal Cancer By Staff Reports 2 years ago Researchers at the University of Toronto have identified a key protein that supports the growth
Biotech Company News Biotechnology Breast Cancer cancer Neurologic Drug Combined with Blood Pressure Medicine Reduces Breast Tumor Development in Mice By Staff Reports 2 years ago Adding a medication used to treat epilepsy, bipolar disorder and migraines to a blood pressure
Biotech Company News cancer Study finds less-aggressive chemotherapy after initial treatment for metastatic colorectal cancer to be more beneficial By Staff Reports 2 years ago A Mayo Clinic study involving 5,540 patients with metastatic colorectal cancer finds that maintenance chemotherapy after initial
Biotech Company News Biotechnology Diabetes Artificial pancreas system better controls blood glucose levels than current technology By Staff Reports 2 years ago A multicenter randomized clinical trial evaluating a new artificial pancreas system — which automatically monitors
age-related decline Alzheimers and Dementia Biotech Company News Biotechnology Bayer Selects Savonix Digital Cognitive Assessment Platform to Validate the Effects of Multivitamin Supplement Berocca in Malaysia By Staff Reports 2 years ago Savonix, a global leader in digital tests for cognitive health, and Bayer’s Consumer Health Division
Biotech Company News Biotechnology cancer Cell Therapy Heart Health Novel Therapeutic Shows Remarkable Efficacy in HepG2 Cell Lines By Staff Reports 2 years ago Q BioMed, Inc. and Chemveda Life Sciences announce the successful chemical synthesis of a unique
Biotech Company News Biotechnology genes Genetic Disorders Genomes genomic sequencing Mutation Discovery Leads to Precise Treatment for Child with Severe Lymphatic Disorder By Staff Reports 3 years ago Faced with a preteen boy in pain and struggling to breathe from a severe, deteriorating
Biotech Company News Biotechnology High Dose of Pfizer’s Xeljanz Raises Red Flag in a Post-Marketing Study By Staff Reports 3 years ago Pfizer‘s blockbuster rheumatoid arthritis drug Xeljanz, a JAK inhibitor, has been a strong performer for
Biotech Company News Merck to Acquire Immune Design By Staff Reports 3 years ago Merck and Immune Design announced that the companies have entered into a definitive agreement under
Biotech Company News Gilead misses key goal in NASH liver disease trial By Staff Reports 3 years ago CHICAGO (Reuters) – Gilead Sciences Inc said on Monday that a late-stage study of a
Biotech Company News Biotechnology Diabetes New Sensor to Monitor Blood Sugar Through a Breath By Staff Reports 3 years ago It’s a breath of fresh air for people with diabetics. A simple puff into a
Biotech Company News cancer Clinical Trials Eureka Therapeutics Announces Us FDA Clearance of IND Application for Phase 1/2 Trial of Et140202 Artemis T-Cell Therapy, For The Treatment of Liver Cancer By Staff Reports 3 years ago Eureka Therapeutics, Inc., a clinical stage biotechnology company developing antibody-TCR (AbTCR) T-cell therapies, announced that